HK1245401A1 - 鑑定、選擇和使用高治療潛力的t細胞表位 - Google Patents
鑑定、選擇和使用高治療潛力的t細胞表位Info
- Publication number
- HK1245401A1 HK1245401A1 HK18104738.9A HK18104738A HK1245401A1 HK 1245401 A1 HK1245401 A1 HK 1245401A1 HK 18104738 A HK18104738 A HK 18104738A HK 1245401 A1 HK1245401 A1 HK 1245401A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- identification
- selection
- cell epitopes
- high curative
- curative potential
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462087002P | 2014-12-03 | 2014-12-03 | |
PCT/US2015/063810 WO2016090177A1 (en) | 2014-12-03 | 2015-12-03 | Identification, selection and use of high curative potential t cell epitopes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1245401A1 true HK1245401A1 (zh) | 2018-08-24 |
Family
ID=55024274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18104738.9A HK1245401A1 (zh) | 2014-12-03 | 2018-04-11 | 鑑定、選擇和使用高治療潛力的t細胞表位 |
Country Status (6)
Country | Link |
---|---|
US (3) | US10317402B2 (zh) |
EP (1) | EP3227679A1 (zh) |
AU (2) | AU2015358387B2 (zh) |
CA (2) | CA2969231C (zh) |
HK (1) | HK1245401A1 (zh) |
WO (1) | WO2016090177A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108026154B (zh) | 2015-07-01 | 2022-03-08 | 伊玛提克斯生物技术有限公司 | 用于卵巢癌和其他癌症免疫治疗的新型肽和肽组合物 |
GB201511546D0 (en) * | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
EP3369431A1 (en) * | 2017-03-03 | 2018-09-05 | Treos Bio Kft | Vaccine |
CA3054861A1 (en) | 2017-03-03 | 2018-09-07 | Treos Bio Zrt | Peptide vaccines |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
US20200360726A1 (en) * | 2017-08-11 | 2020-11-19 | The Regents Of The University Of California | Determination of Tissue Properties for Charged Particle Radiotherapy |
CN107325167B (zh) * | 2017-08-16 | 2021-01-08 | 漯河医学高等专科学校 | 靶向akap3的亲和肽p296 |
CN107365373B (zh) * | 2017-08-16 | 2020-11-03 | 漯河医学高等专科学校 | 靶向akap3的亲和肽p527 |
CN107344964B (zh) * | 2017-08-16 | 2020-10-27 | 漯河医学高等专科学校 | 靶向akap3的亲和肽p333 |
JP2021536487A (ja) | 2018-09-04 | 2021-12-27 | トレオス バイオ リミテッド | ペプチドワクチン |
CA3142386A1 (en) | 2019-06-06 | 2020-12-10 | Immatics Biotechnologies Gmbh | Sorting with counter selection using sequence similar peptides |
AU2020351168A1 (en) * | 2019-09-18 | 2022-04-14 | Children's Medical Center Corporation | An anaplastic lymphoma kinase (ALK) cancer vaccine and methods of use |
GB202004974D0 (en) | 2020-04-03 | 2020-05-20 | Treos Bio Ltd | Coronavirus vaccine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0421355D0 (en) * | 2004-09-24 | 2004-10-27 | Univ Oslo | Inhibitors |
TW201008574A (en) * | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
US9062349B2 (en) | 2011-04-14 | 2015-06-23 | Texas Tech University System | Composition and method for diagnosis and immunotherapy of prostate cancer |
WO2013126785A1 (en) * | 2012-02-22 | 2013-08-29 | Ingenium Biotherapy Corporation | A system for immunotherapy targeting tumor propagation and progression |
JP2016514094A (ja) | 2013-02-12 | 2016-05-19 | テキサス テック ユニヴァーシティー システムTexas Tech University System | 肺がんの診断及び免疫療法のための組成物及び方法 |
-
2015
- 2015-12-03 AU AU2015358387A patent/AU2015358387B2/en not_active Ceased
- 2015-12-03 WO PCT/US2015/063810 patent/WO2016090177A1/en active Application Filing
- 2015-12-03 CA CA2969231A patent/CA2969231C/en active Active
- 2015-12-03 CA CA3116369A patent/CA3116369A1/en not_active Abandoned
- 2015-12-03 US US14/958,780 patent/US10317402B2/en not_active Expired - Fee Related
- 2015-12-03 EP EP15816619.9A patent/EP3227679A1/en not_active Ceased
-
2018
- 2018-04-11 HK HK18104738.9A patent/HK1245401A1/zh unknown
-
2019
- 2019-06-10 US US16/436,344 patent/US11016091B2/en active Active
- 2019-10-21 AU AU2019253775A patent/AU2019253775A1/en not_active Abandoned
-
2021
- 2021-05-24 US US17/328,465 patent/US20210278407A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2019253775A1 (en) | 2019-11-07 |
AU2015358387B2 (en) | 2019-07-25 |
US20210278407A1 (en) | 2021-09-09 |
CA2969231C (en) | 2021-06-08 |
AU2015358387A1 (en) | 2017-06-15 |
CA3116369A1 (en) | 2016-06-09 |
CA2969231A1 (en) | 2016-06-09 |
US20160161486A1 (en) | 2016-06-09 |
EP3227679A1 (en) | 2017-10-11 |
US10317402B2 (en) | 2019-06-11 |
US20190353655A1 (en) | 2019-11-21 |
US11016091B2 (en) | 2021-05-25 |
WO2016090177A1 (en) | 2016-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245401A1 (zh) | 鑑定、選擇和使用高治療潛力的t細胞表位 | |
IL251504B (en) | car expression vector and t cells expressing car | |
ME03407B (me) | Klaudin-6 specifični imunoreceptori i t-ćelijsкi epitopi | |
PT3137505T (pt) | Combinação de lenalidomida e construção polipeptídica e utilizações desta | |
HK1231553A1 (zh) | 功能性細胞狀態的鑒定 | |
SG11201608943VA (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
EP2986091A4 (en) | CONTAINER FOR A DATA CENTER AND DATA CENTER | |
PT3131577T (pt) | Células hospedeiras modificadas e suas utilizações | |
HK1258693A1 (zh) | 高容量,封閉,冷凍保存細胞庫系統及其用途 | |
SG11201610430QA (en) | Growth-independent detection of cells | |
SG11201607173RA (en) | Reactor system and use thereof | |
GB201403107D0 (en) | Permeability and transformation of cells | |
IL247448A0 (en) | Peptides and methods of use | |
GB201408173D0 (en) | Personal vaporizer | |
GB201415379D0 (en) | Gamma T cells and uses thereof | |
GB201412175D0 (en) | Gamma T cells and uses thereof | |
GB201413650D0 (en) | Wallets | |
AU353708S (en) | Handbag |